In our study, the expressions of BRCA2 and XPD are probably elevated in tumour tissue and blood of patients in the early stages of cancer in an effort to increase the DNA repair capacity, which is essential for promoting tumour growth, and the cancer phenotype [39]. Here, ERCC2 is linked to neoplasm.